Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Individual responses vary, but some may notice changes in appetite and weight within the first few weeks of treatment
As of September 2023 it is on the FDA's Category 2 list of bulk drug substances that may not be compounded due to significant safety risks, and the agency has scheduled a Pharmacy Compounding Advisory Committee (PCAC) review for July 2026 covering proposed uses in opioid withdrawal, chronic insomnia, and narcolepsy
This dual benefit is unique among current GLP-3 class peptides
Chronic drinkers face compounded danger from depleted glutathione reserves
US$ 25.03
US$ 21.75
US$ 27.28
US$ 27.38
US$ 29.86
US$ 21.95
US$ 24.81
US$ 28.47
US$ 24.81
